http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
이중언어자에서 보인 두 형태의 실어증 : 증례보고 A Case Report
나해리,이정욱,박성민,박수열,권순용,이현정 대한치매학회 2004 Dementia and Neurocognitive Disorders Vol.3 No.2
Since many people in Korea know more than one language, bilingual aphasia is an important line of research in clinical and theoretical neurolinguistics. Nowadays we meet many people who speak other languages along with Korean, who are immigrants from foreign countries, especially from China. Differential recovery of language affected by an aphasic deficit is documented. In the present work, we introduced a patient with bilingual aphasia who showed different recovery patterns in Korean and Chinese. A 66-year-old man was presented with language disturbance and right hemiplegia. On past medical history, he had received a hematoma evacuation through burr-hole due to left basal ganglia hemorrhage. After the event, he showed nearly global aphasia in Korean, but he showed minimally preserved language function on comprehension and fluency in Chinese. This result suggests that aphasia in bilingual subject may show different pat-terns of recovery between two languages.
Relationship between Lower Urinary Tract Dysfunction and Dementia
Na Hae Ri,조성태 대한치매학회 2020 Dementia and Neurocognitive Disorders Vol.19 No.3
Lower urinary tract dysfunction (LUTD) is a common health challenge in dementia patients with significant morbidity and socioeconomic burden. It often causes lower urinary tract (LUT) symptoms, restricts activities of daily life, and impairs quality of life. Among several LUT symptoms, urinary incontinence (UI) is the most prominent storage symptom in the later stages of dementia. UI in patients with dementia results not only from cognitive impairment, but also from urological defects such as detrusor overactivity. Management of LUTD in patients with dementia is based on multiple factors, including cognitive state, functional impairment, concurrent comorbidities, polypharmacy and urologic condition. Behavioral therapy under caregiver support represents appropriate treatment strategy for UI in these patients. Pharmacological treatment can be considered in patients refractory to behavioral therapy, but it is more effective when combined with behavioral therapy. Antimuscarinics and mirabegron, a beta-3 receptor agonist, are effective for managing storage symptoms involving the LUT. However, anticholinergic side effects in elderly subjects are a concern, particularly when there is a risk of exacerbating cognitive impairment with prolonged use of antimuscarinics. Proper recognition and treatment of LUTD in dementia can improve quality of life in these patients.
일부 만 30세 이상 성인에서 구강건조증 관련요인 분석
한해성 ( Hae Seong Han ),권다애 ( Da Ae Kwon ),김리나 ( Ri Na Kim ),김유나 ( Yu Na Kim ),이결희 ( Gyeol Hui Lee ),이나람 ( Na Ram Lee ),이다정 ( Da Jeong Lee ),이승희 ( Seung Hui Lee ),최준선 ( Jun Seon Choi ) 한국치위생과학회 2013 치위생과학회지 Vol.13 No.1
The aim of this study was to analyze factors related to xerostomia in adults aged 30 years and over. The data were analyzed using the t-test, one-way ANOVA and multiple linear regression analysis in the SPSS version 12.0 program. The results were as follow. 1. The respondents who were older than 51 years old, unemployed and had less than 3 million won of average monthly income were more aware of xerostomia (p<0.05). 2. The respondents who answered poor and moderate for their general and oral health and the group with duplicate medication and comorbidity were more aware of xerostomia (p<0.05). 3. The respondents that had problems in chewing, communication, ordinary activities and complained of pain? discomfort and suffered from anxiety depression were more aware of xerostomia (p<0.001). 4. The respondents that answered frequent dryness on their skin, eyes, lips, and nasal mucosa were more aware of xerostomia (p<0.001). 5. Xerostomia showed highest correlation with quality of life (b=0.436) followed by the number of medications (b=0.239), sense of entire body dryness (b=0.200), feeling of hopelessness (b=0.160) and number of oral mucosa disease symptoms (b=0.099) (p<0.05). According to the results of the study, xerostomia may cause deterioration in quality of life. Thus, it is advised to improve the patient management system among dental professions to prevent various complications caused by xerostomia and conduct regular health education on the cause and management method of xerostomia.
S-487 A case of rhabdomyolysis induced by hypocalcemia
( Hae Ri Kim ),( Yoo Hyung Kim ),( Young Rok Ham ),( Dae Eun Choi ),( Kang Wook Lee ),( Ki Ryang Na ) 대한내과학회 2016 대한내과학회 추계학술발표논문집 Vol.2016 No.1
Background: Rhabdomyolysis is a breakdown of skeletal muscle that manifests as symptoms ranging from a subclinical laboratory abnormality to a life-threatening condition. The causes vary and include exercise, trauma, drugs, and electrolyte imbalance. Hypocalcemia can be a result of rhabdomyolysis, or it can be a rare cause of rhabdomyolysis. We report a case of hypocalcemia as the cause of rhabdomyolysis. Case: A 53-year-old male without any drug history came to our hospital. The patient had been diagnosed with moderate mental retardation 15 years earlier. 1 month before admission, he felt left arm pain and could not extend his left elbow. Both arms had become weakened 1 week previously and he was unable to extend his fingers for the past 3 days. Laboratory results from a local clinic showed serum calcium 6.2 mg/dL, magnesium 2.2 mg/dL, and total vitamin D<4.2 ng/dL. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH). thyroid function tests were in normal ranges. 3 days later, he was admitted to our hospital. Initial laboratory results showed calcium 5.8 mg/dL, phosphorus 2.1mg/dL, magnesium 1.22mg/dL, total vitamin D 22.47 ng/dL, and parathyroid hormone 134.76 pg/mL. Creatinine phosphokinase was more than 15,000 U/L. AST, ALT, and LDH were 353, 88, and 3748 U/L. He had no history of trauma, exercise, or drug use, and antibodies to rule out autoimmune disease were all negative. Rhabdomyolysis induced by hypocalcemia was therefore assumed. After 2 days of calcium gluconate intravenous infusion, his numbness improved. Thereafter, his serum calcium increased. After 10 days of calcium infusion and hydration, his symptoms and laboratory results were improved. Conclusions: Hypocalcemia under 6mg/dL rarely occurs and hypocalcemia-induced rhabdomyolysis is also a rare condition. Most guidelines for rhabdomyolysis recommend against administration of calcium, even if serum calcium is low, because calcium can be released from the muscles after improvement of rhabdomyolysis. We suggest that measuring vitamin D and parathyroid hormone could help physicians to distinguish whether low serum calcium is a result or a rare cause of rhabdomyolysis when deciding on therapeutic options.
( Hae Ri Kim ),( Jae Wan Jeon ),( Eu Jin Lee ),( Young Rok Ham ),( Ki Ryang Na ),( Kang Wook Lee ),( Kee Hong Park ),( Seon Young Kim ),( Dae Eun Choi ) 대한전해질학회 2021 Electrolytes & Blood Pressure Vol.19 No.1
Hypokalemic periodic paralysis (hypoPP) is a disorder characterized by episodic, short-lived, and hypo-reflexive skeletal muscle weakness. HypoPP is a rare disease caused by genetic mutations related to expression of sodium or calcium ion channels. Most mutations are associated with autosomal dominant inheritance, but some are found in patients with no relevant family history. A 28-year-old man who visited the emergency room for paralytic attack was assessed in this study. He exhibited motor weakness in four limbs. There was no previous medical history or family history. The initial electrocardiogram showed a flat T wave and QT prolongation. His blood test was delayed, and sudden hypotension and bradycardia were observed. The blood test showed severe hypokalemia. After correcting hypokalemia, his muscle paralysis recovered without any neurological deficits. The patient’s thyroid function and long exercise test results were normal. However, because of the history of high carbohydrate diet and exercise, hypoPP was suspected. Hence, next-generation sequencing (NGS) was performed, and a mutation of Arg669His was noted in the SCN4A gene. Although hypoPP is a rare disease, it can be suspected in patients with hypokalemic paralysis, and iden tification of this condition is important for preventing further attacks and improving patient outcomes. Diagnosing hypoPP through targeted NGS is a cost-effective and useful method.
Na, Hae‐,Ri,Kim, SangYun,Choi, Seong‐,Hye,Yang, Dong‐,Won,Bae, Hee‐,Joon,Kim, Jung‐,Eun,Park, Mee‐,Young,Shim, Yong‐,Soo,Kim, Byung‐,Kun,Kwon, Jaeȁ Blackwell Publishing Asia 2011 GERIATRICS & GERONTOLOGY INTERNATIONAL Vol.11 No.1
<P><B>Aim: </B> Donepezil has not been evaluated in Korean patients with Alzheimer's disease (AD) for up to 1 year. The objectives of this study were to evaluate the differential efficacy of donepezil in Korean AD patients with and without concomitant cerebrovascular lesions (CVL).</P><P><B>Methods: </B> This study was a 48‐week open‐label trial of donepezil in patients with probable AD of mild to moderate severity. CVL were evaluated through magnetic resonance imaging (MRI) findings within 3 months. Efficacy analyses were performed for cognitive, behavioral and functional outcome measures.</P><P><B>Results: </B> Concomitant CVL were documented in 35 (30.7%) of the patients on MRI. Seventy‐nine (69.3%) of the patients were considered not to have concomitant CVL. The mean Mini‐Mental State Examination scores of both patients with and without CVL showed improvement at each evaluation. However, there was no statistical difference in improvement between the groups.</P><P><B>Conclusion: </B> The presence of CVL should not deter clinicians from treating AD with donepezil. <B>Geriatr Gerontol Int 2011; 11: 90–97.</B></P>